Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in immunology in multiple sclerosis

R S Liblau1, B Fontaine

  • 1Department of Neurology, INSERM CJF9608, Salpetriere Hospital, Paris, France.

Current Opinion in Neurology
|September 2, 1998
PubMed
Summary

This review explores recent immunology advances in multiple sclerosis (MS), focusing on T cell and oligodendrocyte death, infectious agents, and interferon-beta therapy. These insights enhance understanding of MS immunopathology and therapeutic options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous determination of 8 beta-lactams and linezolid by an ultra-performance liquid chromatography method with UV detection and cross-validation with a commercial immunoassay for the quantification of linezolid.

Talanta·2020
Same author

Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.

Journal of neuroinflammation·2015
Same author

Combined theoretical and time-resolved photoluminescence investigations of [Mo₆Brⁱ₈Br(a)₆]²⁻ metal cluster units: evidence of dual emission.

Physical chemistry chemical physics : PCCP·2015
Same author

Neuromyelitis optica: a positive appraisal of seronegative cases.

European journal of neurology·2015
Same author

Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.

Neuromuscular disorders : NMD·2014
Same author

A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.

Genes and immunity·2014

Area of Science:

  • Neuroimmunology
  • Central Nervous System Diseases
  • Autoimmune Disorders

Background:

  • Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS).
  • The exact cause of MS is unknown, but it is suspected to have an autoimmune origin.
  • Understanding the immunopathology of MS is crucial for developing effective treatments.

Purpose of the Study:

  • To review recent advances in the immunology of multiple sclerosis.
  • To discuss the role of T cells and oligodendrocyte death in inflammatory lesions.
  • To examine the potential involvement of infectious agents in MS pathophysiology.
  • To explore the mechanism of action of interferon-beta in MS treatment.

Main Methods:

  • Review of recent scientific literature on multiple sclerosis immunology.

Related Experiment Videos

  • Analysis of experimental evidence regarding T cell and oligodendrocyte interactions.
  • Examination of data on infectious agents and CNS autoimmune diseases.
  • Synthesis of information on interferon-beta's therapeutic effects.

    • Main Results:

    • Inflammatory lesions in MS involve T cell and oligodendrocyte death.
    • Experimental evidence suggests infectious agents may contribute to MS.
    • Interferon-beta's mode of action in MS is being elucidated.
    • Recent advances provide a deeper understanding of MS immunopathology.

    Conclusions:

    • New insights into MS immunology are emerging from research on T cells, infectious agents, and interferon-beta.
    • A better understanding of MS immunopathology opens avenues for novel therapeutic strategies.
    • Continued research in neuroimmunology is vital for advancing MS treatment and patient outcomes.